Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study

DOI: 10.1186/s40880-018-0294-z

Keywords: Bevacizumab, Neoadjuvant chemoradiotherapy, Locally advanced rectal cancer, Safety, Efficacy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Baseline characteristics of 45 patients with locally advanced rectal cancer enrolled in the present stud

Full-Text